Anavex Life Sciences Corp (AVXL)

[ridinbulls]

Phase 2b will have to be completed in this case. Disease state and how aggressive or deadly it is are usually the only possibility for skipping through a trial. Not to say this disease state isn't that but the disease progression is over a longer period of time then say aggressive type cancers for example.

Phase IIb in this particular trial is the portion that is the collection of various data points and many of which will be used to design the best trial for a phase III by giving the correct dosage for optimal response aka efficacy. They will have to have this information for not only the FDA but for making sure they have the best chance to move into phase III and increase their likelihood achieve success.

AIMO